Long-Term Safety, Rollover Study of Adjunctive Everolimus in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures Who Continue to Benefit from Everolimus Treatment after Completion of EXIST-3

Yapici Z., Fan P. -. , Lawson J. A. , Belousova E., Gazri H. E. , Ridolfi A., ...More

13th European Congress on Epileptology, Vienna, Austria, 26 - 30 August 2018, vol.59 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 59
  • City: Vienna
  • Country: Austria